Sphere Fluidics will be attending the “PEGS Europe Protein and Antibody Engineering Summit” to be held in Lisbon (Portugal) on 4th-8th November 2013. The conference has various sessions on: Antibody Engineering, Cancer Biotherapeutics, Development of Novel Biotherapeutics and Protein Engineering. Dr Frank F. Craig (CEO) said, “This should be a superb conference for Sphere Fluidics as we are developing single cell technology that enables unique science and discoveries in these sectors”. Conference information can be found here.
Sphere Fluidics will be attending and exhibiting at a forthcoming “Labs to Riches” event to be held in London on October 31st 2013. This annual event is organised by the Royal Society. It involves not only an exhibition of the Royal Society Enterprise Fund’s portfolio companies but brings together Royal Society Fellows, business leaders and investors for an Annual Awards dinner. “We look forward to presenting to such an exclusive audience and meeting with the UK’s science and business leaders”, said Dr Frank F. Craig (CEO). Some more information can be found here.
Dr Rob Marchmont (Commercial Director) and Dr Xin Liu (R&D Senior Scientist) will be attending “MicroTAS 2013” on the 27th-31st of October 2013. The conference will be held in Freiburg (Germany) and is one of the world’s largest conferences on microfluidics. Dr Rob Marchmont says “The conference provides an excellent overview on scientific advances in this area and I look forward to developing new alliances and meeting with our existing (now around 100) or new customers”. Conference information can be found here.
Dr Frank F. Craig (CEO of Sphere Fluidics Ltd) will be talking at a Knowledge Exchange Forum to be held at the Babraham Research Campus on 22nd October 2013. “This will be a useful forum to share ideas and meet with other companies and scientific groups on campus” he said, “I look forward to giving updates on our Single Cell Analysis technology”.
In an interview with Reed (a global recruitment specialist), Dr Frank F. Craig (CEO) of Sphere Fluidics discusses recruitment, retention and motivation of scientists in a start-up company. Among other statements, he says” The bottom line is that, if you don’t have the best people, you don’t have the best company”. Details on the full inteview is available in InScientific Issue 1 and online here.
Dr Rob Marchmont (Commercial Director of Sphere Fluidics) will be attending the “BioIndustry Association UK Bioscience Forum” in London on the 10th of October 2013. “The conference agenda gives valuable insights into industry directions and has interesting seminars into biologics, a major commercial area of interest for Sphere Fluidics. I also look forward to the interactive Biopartnering meetings” he said. Conference information can be found here.